Heart Failure Information Center Archive
Patients with heart failure might have a greater risk for cardiovascular comorbidities and hearing loss.
In patients undergoing TAVR or SAVR, approximately 1 in 3 had depressive symptoms at baseline and a higher risk of short-term and midterm mortality.
A 55-year-old obese woman with hypertension, diabetes, and scleroderma is referred for follow-up after a recent admission for new-onset heart failure.
Treating patients with ruptured abdominal aortic aneurysms with endovascular strategy over open repair may increase survival and decrease cost.
In patients with depressive symptoms, vitamin D deficiency with no additional supplements had the highest depressive score at 6 months and shortest cardiac event-free survival.
NT-proBNP-guided treatment strategy did not improve outcomes compared with a usual care strategy in high-risk patients with heart failure.
A 30-year-old woman presents with an increased heart rate, shortness of breath, and tingling in her right arm.
Data from a clinical trial show that patients taking daily aspirin were not at heightened risk of being hospitalized for heart failure.
Primary care providers can help significantly reduce heart failure exacerbations and improve their patients' overall quality of life.
There were 526.86 hospital admissions for every 100,000 people in 2002, compared with 364.66 per 100,000 in 2013.
Clinicians will encounter more patients at risk for CHF as the population ages and cardiovascular risk factors become more prevalent.
Researchers also observed no difference in 30-day mortality rates between patients in the ICU and those who received regular inpatient care in another hospital unit.
Ambulatory high-dose intravenous diuretic therapy could be cost saving compared with hospitalization for intravenous loop diuretic therapy.
Some individual NSAIDs may be linked to increased risk of hospital admission for heart failure.
The American Heart Association has published a scientific statement that outlines which medications cause or exacerbate heart failure.
At 16 months, 30.3% of patients either died or experienced worsening heart failure.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
Patients with coronary artery disease who were previously not considered candidates for CABG may benefit from the surgery.
Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.
Patients who were obese and underwent bariatric surgery saw a significant reduction in heart failure-related exacerbation events.
Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.
A one-point increase in the American Heart Association's Life's Simple 7 checklist correlated to a 23% lower risk of developing heart failure.
Patients with heart failure who receive the influenza vaccine may have a lower risk for all-cause mortality compared with those who do not get the vaccine.
Researchers found a 15% to 20% reduction in the risk of hospitalization for or death from heart failure in patients who received cardiac resynchronization therapy with defibrillator (CRT-D).
Premature birth has been associated with a number of adverse health conditions.
Chronic heart failure patients who restrict sodium intake may have an increased risk of death or hospitalization.
Researchers have linked pulse pressure to adverse outcomes in heart failure patients with both reduced ejection fraction and preserved ejection fraction.
Researchers examined the effectiveness of diuretic treatment for volume management in patients with chronic heart failure and evidence of worsening congestion.
Researchers on the BEAT-HF trial have concluded that, in patients with chronic heart failure, mirabergron failed to improve left ventricular ejection fraction.
Vericiguat well tolerated but not statistically significant in reducing natriuretic peptide level in patients with chronic heart failure
A phase 2 trial of the drug vericiguat did not show a statistically significant reduction of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients with worsening chronic heart failure.
Elevated total bilirubin, transaminases reported in chronic heart failure patients with poor prognosis
Researchers evaluate the echocardiographic correlates of elevated total bilirubin and transaminases in patients with chronic heart failure.
A study published in The American Journal of Cardiology shows that newer antianginal (AA) medications - including ranolazine - show substantial outcome improvements when compared to traditional AA medications.
Regularly drinking sweetened beverages can increase the risk of heart failure in men by 23% compared with those who do not consume these drinks.
The American College of Cardiology has published a guideline for the management of supraventricular tachycardia (SVT) in adult patients.
Reaching a systolic pressure of 120 mm HG reduces the risk of heart attack, heart failure, and stroke by a third.
Extremely high and low amounts of physical activity increase heart failure risk in men.
Older adults who exercise, drink moderately, don't smoke, and have a healthy weight have a lower risk of heart failure.
Premature ventricular contractions may be a modifiable risk factor for heart failure and death.
Entresto significantly reduced rates of cardiovascular death and hospitalization in heart failure.
Risk prediction model could help determine patients at greater risk for 30-day readmission.
Women's risk for heart attack can be significantly lowered through six healthy lifestyle practices.
The researchers found that 38% of obese and 45% of overweight patients died over 10 years, compared with 51% of normal-weight patients.
A woman complaining of seeing yellow lights is diagnosed with digoxin toxicity.
Screening elderly patients for heart failure and chronic obstructive pulmonary disease can increase detection.
Leisure-time physical activity was inversely related to risk of developing heart failure in this study from Circulation: Heart Failure.
Heart failure patients receiving continuity care after ED discharge were less likely to experience hospitalization or death.
After listening to a patient, this clinician urged an in-person visit that led to an ED admission for atrial fibrillation and heart failure.
Patients with both conditions had longer than average hospital stays, greater in-hospital mortality, and a higher rate of discharge to long-term care facilities.
Complaints about lack of sleep and postnasal drip may describe worsening heart failure.
Association not strong enough to establish causality, but important as more states consider legalizing the drug.
The FDA will investigate possible links between the diabetes drugs Onglyza and Kombiglyze XR and heightened risk for heart failure among users.
Low physical activity and high sedentary time are associated with an increased risk for heart failure among middle-aged men.
Adults who increase their fitness level in midlife or maintain high fitness levels have lower heart failure hospitalization rates later.
Among patients receiving their first ICD, using long-detection intervals reduced the number of inappropriate shocks delivered.
U.S. heart failure (HF) hospitalizations decreased by 29.5% during the past decade, data from a fee-for-service Medicare claims analysis conducted from 1998 to 2008 indicate.
Adding a tai chi exercise program to standard medical care may help improve quality of life and mood among patients with heart failure.
Previous trials investigating cardiac resynchronization therapy (CRT) (biventricular pacing) combined with an implantable cardioverter defibrillator (ICD) in patients with heart failure have shown nonsignificant improvements in mortality compared with ICD monotherapy. But a newer study has promising results.
I seem to be seeing a lot more hyponatremia. Some of these patients are taking diuretics, while others have psychogenic polydipsia or syndrome of inappropriate antidiuretic hormone secretion (SIADH). Others have no known cause. Is there an explanation for this increase?
Women experienced greater reductions in HF and death after CRT-D than men.
American Heart Association estimates 40.5% of Americans will develop some form of cardiovascular disease.
Clinicians should be aware of cardiovascular risks with NSAIDs and COX-2 inhibitors.
Characterized by impaired myocardial performance, heart failure is often misdiagnosed. Clinicians should focus on prevention and early detection
Ivabradine is a novel agent that lowers heart rate by inhibiting the I(f) current in the sinoatrial node.
Some individuals develop hyponatremia when on a diuretic — not because the sodium level is diluted, but because the diuretic causes the sodium to be excreted with the excess fluid.
In rural health-care settings, many patients are reluctant to use insulin.
This amino acid is mainly taken for its vasodilatory effects, but serious safety issues limit its use.
Variability in a patient's BP is a strong predictor of stroke, heart failure, angina, and MI.
Neither beta blockers nor calcium channel blockers given during the first 24 hours were found to reduce all-cause mortality.
The patient seemed to have GERD and responded to treatment. But then he had a fatal heart attack.
Diagnosing atrial fibrillation could sharply reduce strokes in the United States, and primary-care providers have a key role to play.
Young African Americans are developing heart failure (HF) before age 50 years at a rate 20 times higher than whites.
Exercise improves blood vessel function after myocardial infarction—but only as long as the patient sticks with it.
But increase stroke and may increase mortality
Registered dietitians have some new advice for your patients with heart failure or chronic obstructive pulmonary disease.
Fatigue, fever, and chills plague a patient following valve replacement. The solution requires a multidisciplinary approach.
A large study has shown that aspirin and antioxidant supplements are ineffective in the primary prevention of heart attacks in people with diabetes and asymptomatic arterial disease
The FDA has approved Trilipix (fenofibric acid), a delayed-release capsule for use along with diet to treat dyslipidemia. Trilipix is the first fibrate to be approved for use in combination with a statin.
Blood sugar goals, stem cells, CT scans, health reform--these are some of the issues to make the list of most important stories of the year, as chosen by the Harvard Health Letter.
A recent report found that office BP has no value in predicting cardiovascular (CV) morbidity and mortality in patients with resistant hypertension. Higher ambulatory measurements, however, are good indicators of these outcomes, according to the same report.
The Three Interventions in Cardiogenic Pulmonary Oedema (3CPO) trial evaluated ventilation strategies for patients with respiratory distress due to acute heart failure...
The GISSI-HF randomized placebo-controlled trial also evaluated n-3 polyunsaturated fatty acids (PUFAs) in 357 cardiology or internal medicine centers in Italy...
The Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) randomized placebo-controlled trial evaluated rosuvastatin (Crestor) in 357 cardiology or internal medicine centers in Italy.
We seem to use beta-agonists for everything that wheezes these days. While these agents are technically for asthma, we routinely use...
Identifying patients at higher risk for mortality and morbidity during the perioperative period can lead to strategies to minimize those risks.
According to new recommendations, patients once considered to be "prehypertensive" now require more than just lifestyle modification.